• How the INNODIA Detect Program Works
INNODIA will provide all its clinical site Members with:
1. master protocols for detecting islet autoantibodies (IAb) and for monitoring people IAb positive
2. tests to perform IAb screening for up to 100 individuals/year (average)
3. matchmaking support to connect clinical trials' Sponsors with Members monitoring individuals in early T1D stages
• How do we use the information gathered through the INNODIA Detect Program
When medicine developers reach out with clinical trial opportunities for pre-symptomatic T1D people, INNODIA will connect them with the INNODIA clinical site Members where these individuals have been identified to facilitate their participation in the trials.
• Do you want to start detecting Early Type 1Diabetes now?
We recognize the importance of leveraging momentum at its peak.
Whether your site is:
- a INNODIA Clinical Site Member awaiting to be enrolled in the Detect Program
- a European clinical site interested in joining INNODIA Detect Program but not yet a member of the network
- a clinical site outside Europe looking for guidance on Early T1D Screening
You are in the right place! Our master protocols are free to download for all clinical sites; here you can find the master protocols for use:
- IAb Detect Master Protocol: guides the identification of islet autoantibody-positive (IAb+) individuals. [Infographic]
- IAb+ Monitor Master Protocol: supports the monitoring of IAb+ individuals over time. [Infographic]
We encourage all sites to adopt the INNODIA IAb Detect and IAb+ Monitor Master Protocols with necessary adaptations (e.g., conducting IAb diagnostic testing according to local practices) and to collect data using the provided file (link coming soon), even as formal approvals are underway.
IAb DETECT Infographics
IAb+ Monitor Infographics
